Filtered By:
Specialty: Research
Therapy: Cancer Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 57 results found since Jan 2013.

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
Conclusion: The current investigation focuses on designing a multifunctional drug delivery platform for concurrent delivery of either PAC or PARP inhibitor (olaparib) and FOXM1 siRNA in chitosan-coated poly(D, L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) with the ability to emerge as a front runner therapeutic for TNBC therapy.PMID:34336608 | PMC:PMC8314031 | DOI:10.34172/bi.2021.27
Source: BioImpacts - August 2, 2021 Category: Research Authors: Ranjita Misra Bamadeb Patra Sudha Varadharaj Rama Shanker Verma Source Type: research

SEMA4D Knockdown Attenuates < em > β < /em > -Catenin-Dependent Tumor Progression in Colorectal Cancer
This study identifies the inhibitory effects of SEMA4D gene silencing on tumor progression. Thereby, this might conclude a possible alternative to cancer therapy by targeting several prominent pathways involved in cancer through SEMA4D suppression.PMID:34337054 | PMC:PMC8321723 | DOI:10.1155/2021/8507373
Source: Biomed Res - August 2, 2021 Category: Research Authors: Mahsa Rezaeepoor Golnaz Rashidi Mona Pourjafar Chiman Mohammadi Ghasem Solgi Rezvan Najafi Source Type: research

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
Conclusion: The current investigation focuses on designing a multifunctional drug delivery platform for concurrent delivery of either PAC or PARP inhibitor (olaparib) and FOXM1 siRNA in chitosan-coated poly(D, L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) with the ability to emerge as a front runner therapeutic for TNBC therapy.PMID:34336608 | PMC:PMC8314031 | DOI:10.34172/bi.2021.27
Source: BioImpacts - August 2, 2021 Category: Research Authors: Ranjita Misra Bamadeb Patra Sudha Varadharaj Rama Shanker Verma Source Type: research

SEMA4D Knockdown Attenuates < em > β < /em > -Catenin-Dependent Tumor Progression in Colorectal Cancer
This study identifies the inhibitory effects of SEMA4D gene silencing on tumor progression. Thereby, this might conclude a possible alternative to cancer therapy by targeting several prominent pathways involved in cancer through SEMA4D suppression.PMID:34337054 | PMC:PMC8321723 | DOI:10.1155/2021/8507373
Source: Biomed Res - August 2, 2021 Category: Research Authors: Mahsa Rezaeepoor Golnaz Rashidi Mona Pourjafar Chiman Mohammadi Ghasem Solgi Rezvan Najafi Source Type: research